Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

133 results about "Virus types" patented technology

Three types of viruses cause influenza, more commonly known as the flu. Influenza virus types A and B cause seasonal flu infections, which typically occur from late fall through early spring. Influenza type C infections occur far less frequently and typically cause a mild form of the illness.

Capture probe for rubella virus full-length genome detection and kit and application thereof

The invention provides a capture probe for rubella virus full-length genome detection and a kit and application thereof, and belongs to the technical field of genome sequencing. The invention discloses a capture probe for detecting a rubella virus full-length genome. The nucleotide sequence of the capture probe is shown as SEQ ID NO: 1-SEQ ID NO: 796. The invention also provides a method for detecting the overall length of the rubella virus genome based on the capture probe and next-generation sequencing, and the capture probe not only realizes 100% genome coverage on any rubella virus, but also realizes full-length detection of the rubella virus genome. And the purposes of rubella virus variation monitoring and virus type traceability can be realized by depending on the rubella virus genome sequence information obtained by the method.
Owner:STATION OF VIRUS PREVENTION & CONTROL CHINA DISEASES PREVENTION & CONTROL CENT

Application of isochlorogenic acid C in preparation of medicine for resisting respiratory syncytial virus type A strain

The invention discloses application of isochlorogenic acid C in preparation of a medicine for resisting a respiratory syncytial virus A type strain, and belongs to the technical field of medicine. Experiments prove that the isochlorogenic acid C has an obvious inhibiting effect on the respiratory syncytial virus type A strain, so that the isochlorogenic acid C has an important application value when being used as an active ingredient for preparing the respiratory syncytial virus type A strain medicine.
Owner:湖北江夏实验室 +1

Capture probe for detecting whole genome of human parainfluenza virus as well as kit and application thereof

The invention provides a capture probe for detecting a human parainfluenza virus whole genome and a kit and application thereof, and relates to the technical field of gene sequencing. The capture probe composition disclosed by the invention comprises probes of which the sequences are shown as SEQ ID NO. 1 to SEQ ID NO. 947. The capture probe composition disclosed by the invention can fully cover the full-length genome of the human parainfluenza virus type 1-4, and has the characteristics of uniformity, specificity and high capture efficiency on a captured region. According to the method, the whole genome sequence of the human parainfluenza virus can be more economically and efficiently obtained through probe hybridization capture and next-generation sequencing technologies, and the purposes of human parainfluenza virus variation monitoring and virus type traceability can be achieved depending on sequence information.
Owner:STATION OF VIRUS PREVENTION & CONTROL CHINA DISEASES PREVENTION & CONTROL CENT

Reagent and method for detecting berberine-resistant virus

The invention discloses a reagent and a method for detecting berberine-resistant viruses. The reagent provided by the invention comprises an antibody or an antigen binding fragment thereof, the antibody or the antigen binding fragment thereof comprises a heavy chain complementarity determining region HCDR1-3 and / or a light chain complementarity determining region LCDR1-3, the heavy chain complementarity determining region HCDR1-3 has a sequence as shown in SEQ ID NO.5-7, and the light chain complementarity determining region LCDR1-3 has a sequence as shown in SEQ ID NO.8-10. The reagent can be used for detecting the berberine-resistant herpes simplex virus type 1, so that the treatment effect can be evaluated in advance before berberine is applied for treatment.
Owner:北京市延庆区疾病预防控制中心(北京市延庆区卫生健康监督所) +1

Foot-and-mouth disease virus O-type internal broad-spectrum neutralizing swine monoclonal antibody and application thereof

The invention belongs to the field of biology, and discloses a foot-and-mouth disease virus O-type inner broad-spectrum neutralizing swine monoclonal antibody and application thereof, the amino acid sequence of a heavy chain variable region of the monoclonal antibody is shown as SEQ ID NO.1, the amino acid sequence of a light chain variable region of the monoclonal antibody is shown as SEQ ID NO.2, the antigen key amino acid residue recognized by the monoclonal antibody is VP2 protein 77 site, and the amino acid sequence of the heavy chain variable region of the monoclonal antibody is shown as SEQ ID NO.1. The amino acid sequence of the light chain variable region of the monoclonal antibody is shown as SEQ ID NO.2. The site is located at a structural protein VP2B-C ring, is a conformational epitope, does not react with an A-type antigen, is an intra-strain broad-spectrum neutralizing antibody, and shows relatively strong neutralizing efficacy (IC50 is less than 5 [mu] g.mL <-1 >). Meanwhile, the invention also provides application of the monoclonal antibody.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Novel chimeric flagellin and application thereof

The invention provides a novel chimeric flagellin and application thereof. The novel chimeric flagellin is formed by chimeric combination of a Senecavirus A VP2 fragment and an escherichia coli Nissle 1917 flagellin FliC through Linker (GGGGS) 3, soluble expression of the novel chimeric flagellin in an escherichia coli system is achieved, and the highest yield can reach 200 mg / L. In addition, through detection of in-vitro Caco2 and Raw264.7 cell models, the recombinant novel chimeric flagellin shows good TLR5 receptor activity, and can effectively activate a TLR5 signal channel.
Owner:LANZHOU UNIV

Animal vaccination risk prediction method and system based on cross-modal large model

The invention provides an animal vaccination risk prediction method and system based on a cross-modal large model, and relates to the technical field of vaccination risk prediction. Comprising a multi-modal data acquisition and integration module, a cross-modal feature extraction and semantic alignment module, a pre-training model construction and transfer learning module, a risk prediction and decision support module and a model verification and iterative optimization module. Misjudgment caused by same surface symptoms can be effectively avoided, in animal epidemic disease diagnosis, similar symptoms may be caused by different viruses, a traditional method is easily interfered by surface phenomena, and the optimized method can be used for diagnosis of animal epidemic diseases by constructing a causal diagram, analyzing real causes of symptoms and stripping confounding factors such as environment and physiological status. Through the means, the model can more accurately distinguish virus types, the misjudgment risk is remarkably reduced, and a reliable basis is provided for a subsequent vaccination strategy.
Owner:潘海澄

Application of fructose-1, 6-diphosphate in preparation of medicine for preventing and treating herpes simplex virus type 1 infection

The invention belongs to the field of medicines, and particularly relates to application of fructose-1, 6-diphosphate in preparation of a medicine for preventing and treating herpes simplex virus type 1 infection. The fructose-1, 6-diphosphate (FBP) can be used for inhibiting replication of RNA (Ribonucleic Acid) and DNA (Deoxyribose Nucleic Acid) viruses in vitro and in vivo. Experiments show that the inhibition effect does not depend on I-type interferon-mediated innate immunity to a great extent, but occurs through HMGB1 (High Mobility Group Box 1). After virus infection, FBP reduces the protein level of HMGB1 by promoting lysosome degradation of HMGB1. In addition, the FBP can directly inhibit the combination of the HMGB1 and the viral genome, so that the virus replication is inhibited. The key effect of FBP in inhibition of virus replication is highlighted through research, and a potential target spot for controlling virus infection is provided.
Owner:SICHUAN ACADEMY OF MEDICAL SCI SICHUAN PROVINCIAL PEOPLES HOSPITAL

Non-invasive method and kit for capturing and isolating fetal cells from mother

ActiveUS12163127B2VectorsVirus peptidesWild typePrenatal screening
Provided are a promoter of a gene specifically expressed in fetal trophoblast cells and a gene specifically expressed in fetal nucleated red blood cell-specific expression gene, as well as a recombinant herpes simplex virus type I obtained by replacing the wild type promoter of the genomic ICP of the recombinant herpes simplex virus type I with the aforesaid promoter and preparation and use thereof. Also provided are a diagnostic kit for prenatal screening and use thereof, as well as a method for isolating fetal cells from a maternal blood sample in pregnancy.
Owner:WUHAN HEZEE BIOTECHNOLOGY CO LTD

Primer probe combination and kit for identifying and detecting African swine fever typing, wild virus and deletion virus

PendingCN118996007AMeet the needs for accurate identificationquick distinctionMicrobiological testing/measurementMicroorganism based processesAfrican swine feverVaccine virus
The invention provides a primer probe combination and a kit for identifying and detecting African swine fever typing, wild virus and deletion virus, and belongs to the technical field of virus detection. The primer probe combination comprises a specific primer and probe combination aiming at ASFV I-type attenuated virus, I-type virulent virus, II-type attenuated virus, II-type wild virus and I177L gene deleted vaccine virus, and multiple detection is carried out by utilizing probes labeled by different fluorescently. The kit can quickly and accurately distinguish the various virus types in one PCR reaction, and has high specificity and high sensitivity, and the lowest detection limit can reach 2.29 copies / [mu] L or 4.15 copies / [mu] L. Meanwhile, experimental results show that the method has good repeatability and reliability and is suitable for ASFV diagnosis detection and epidemiological investigation.
Owner:XIAJIN NEW HOPE LIUHE AGRICULTURE & ANIMAL HUSBANDRY CO LTD +5

Foot and mouth disease virus type A broad-spectrum neutralizing swine monoclonal antibody and application thereof

The invention discloses a foot-and-mouth disease virus type A broad-spectrum neutralizing swine monoclonal antibody and application of the foot-and-mouth disease virus type A broad-spectrum neutralizing swine monoclonal antibody. The amino acid sequence of a heavy chain variable region of the antibody PAF56 is shown as SEQ ID No.12, the sequence of a heavy chain CDR1 is GFGFSNTY, the sequence of a heavy chain CDR2 is VFTGGGAT, and the sequence of a heavy chain CDR3 is VSNRDGFGGVGNV. An amino acid sequence of a light chain variable region is shown as SEQ ID No.13, a light chain CDR1 sequence is SGSVTSLNY, a light chain CDR2 sequence is RTN, and a light chain CDR3 sequence is ALYKGSGTDTNI. The antibody PAF56 can be used for simultaneously neutralizing an AF72 strain of an A22 pedigree, and has A-type FMDV broad-spectrum neutralizing activity with A / WH / CHA / 09 and A / GDMM / 2013 epidemic strains of a domestic SEA97 pedigree. PAF56 recognizes an antigen site 2 of a VP2 B-C ring, a key amino acid is VP2 D72, and the recognized site is highly conserved in A-type FMDV. According to the invention, one natural host source type A specific FMDV broad-spectrum neutralizing antibody is obtained for the first time, and a key antigen site identified by the antibody is identified, so that a powerful tool is provided for establishment of FMDV antigen structure analysis and serological detection methods.
Owner:LANZHOU VETERINARY RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES(LANZHOU BRANCH CENTER OF CHINA ANIMAL HEALTH & EPIDEMIOLOGY CENTER)

Broad-spectrum neutralizing monoclonal antibodies from pigs against foot-and-mouth disease virus types O, A and Asia1 and their application

The present invention discloses broad-spectrum neutralizing porcine monoclonal antibodies pOA-6, pOA-13 and pOA-20 against foot-and-mouth disease virus type O, type A and Asia1. The amino acid sequences of the heavy chain variable region and light chain variable region of pOA-6 are shown as SEQ ID No.1 and SEQ ID No.2, respectively; the amino acid sequences of the heavy chain variable region and light chain variable region of pOA-13 are shown as SEQ ID No.3 and SEQ ID No.4, respectively; the amino acid sequences of the heavy chain variable region and light chain variable region of pOA-20 are shown as SEQ ID No.5 and SEQ ID No.6. The present invention obtains for the first time three strains of natural host-derived O-type, A-type and Asia1 FMDV broad-spectrum neutralizing antibodies, and identifies the key antigenic sites recognized by them, providing a powerful tool for the development of FMDV antibody drugs and the establishment of serological detection methods.
Owner:LANZHOU VETERINARY RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES(LANZHOU BRANCH CENTER OF CHINA ANIMAL HEALTH & EPIDEMIOLOGY CENTER)

Preparation method of pseudoviruses of herpes simplex virus type 1, herpes simplex virus type 2 and human adenovirus type F and application of pseudoviruses in molecular detection

The invention provides a herpes simplex virus type 1, herpes simplex virus type 2, a human adenovirus type F pseudovirus, a preparation method and application thereof, and relates to the technical field of pathogen nucleic acid detection.The HSV1 / HSV2 / HAdV-F pseudovirus contains independent conserved gene amplification sequences of an HSV1 virus, an HSV2 virus and an HAdV-F virus; the kit can be applied to detection of nucleic acid sequences of three common human herpes viruses HSV1 / HSV2 / HAdV-F in a sample, and can be used as a positive control. Meanwhile, the practical application of the HSV1 / HSV2 / HAdV-F pseudovirus in qPCR (quantitative polymerase chain reaction) detection can be used for quantitative analysis of the three human viruses in experimental animal models, is also suitable for human virus factor inspection of animal cell matrixes for biological product production and animal cells for verification, and plays an important role in safety of biological products.
Owner:北京昭衍药物检定研究有限公司

A tobacco virus classification model construction method based on tobacco hyperspectral

The application provides a tobacco virus classification model construction method based on tobacco leaf hyperspectrum, and belongs to the technical field of tobacco virus classification models. Fractional differential spectrum enhancement processing is adopted, persistent homology eigenvalues and Betti number sequence values are calculated through spectrum topological manifold embedding of enhanced spectrum data, dimension reduction is performed through kernel principal component analysis to obtain topological embedding feature vectors, fusion feature vectors are output through a multimodal attention fusion module in combination with thermal infrared temperature field data and chlorophyll fluorescence kinetic curve data, data enhancement is performed on minority class samples by using a spectral generative adversarial network, the fusion feature vectors are input into a virus classification and recognition model adopting a focal loss function and a dynamic network adjustment mechanism for training, virus type classification and disease severity grade recognition of tobacco leaves to be tested are realized, and the problem that different types of tobacco viruses cannot be accurately recognized and distinguished in the early stage of disease is solved.
Owner:TOBACCO RESEARCH INSTITUTE OF CHINESE ACADEMY OF AGRICULTURAL SCIENCES (QINGZHOU TOBACCO RESEARCH INSTITUTE OF CHINA NATIONAL TOBACCO COMPANY)

Foot-and-mouth disease virus type O specific neutralizing swine monoclonal antibody and application thereof

The invention discloses a neutralizing swine monoclonal antibody pO18-40 and a neutralizing swine monoclonal antibody pO18-43 for foot and mouth disease virus type O. The amino acid sequences of a heavy chain variable region (VH) and a light chain variable region (VL) of the antibody pO18-40 are respectively as shown in SEQ ID No. 1 and SEQ ID No. 2; the amino acid sequences of VH and VL of the antibody pO18-43 are respectively as shown in SEQ ID No. 3 and SEQ ID No. 4. The antibody obtained by the invention is a full-swine-source antibody, can specifically neutralize the classical strain of the O-type foot-and-mouth disease virus, and can clearly distinguish the classical strain of the O / Cathay topological type from the variant strain of the O / Cathay topological type. A key antigen epitope recognized by the antibody is located at the 149th amino acid of a VP1 protein G-H ring, and the site is a key site of O / Cathay strain antigen variation and vaccine immune protection. The antibody provided by the invention provides an important tool and theoretical basis for serological detection of O-type FMDV, vaccine immune effect evaluation and optimal design of broad-spectrum vaccines.
Owner:LANZHOU VETERINARY RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES(LANZHOU BRANCH CENTER OF CHINA ANIMAL HEALTH & EPIDEMIOLOGY CENTER)

Monkey varicella virus TaqMan fluorescent quantitative PCR (Polymerase Chain Reaction) primer group and application

The invention provides a monkey varicella virus TaqMan fluorescent quantitative PCR primer group and application, and relates to the technical field of molecular biology. A conserved region of a monkey varicella virus type 9 genome is used as a target gene, two specific primers and one probe are designed according to the basic principle of TaqMan real-time fluorescent PCR, and a simple, convenient, efficient and practical detection method is established. The monkey varicella virus detection method disclosed by the invention has a good linear relation in a 101-1011 copy / microliter template range, the sensitivity reaches 1 * 101 copy / microliter, a specific amplification curve is only provided for monkey varicella viruses, and the repeatability is relatively good. The monkey varicella virus is accurately quantified in real time through TaqMan fluorescent quantitative PCR, the urgent need for accurately diagnosing monkey varicella virus infection in the early clinical stage can be met, and a basis is provided for epidemiological investigation and targeted treatment of monkey varicella virus infection.
Owner:INST OF MEDICAL BIOLOGY CHINESE ACAD OF MEDICAL SCI

Human t-cell lymphotropic virus type 1 targeting proteins and methods of use

Provided herein, inter alia, are compositions for treating Human T-cell lymphotropic virus type 1 (HTLV-1) associated diseases. The compositions include a protein having a zinc finger domain capable of binding a sequence within an HTLV-1 long terminal repeat (LTR). Further provided are methods of treating HTLV-1 associated diseases in a subject in need thereof. The methods include administering to the subject the protein including the zinc finger domain, or a nucleic acid encoding the protein.
Owner:CITY OF HOPE

Aarenavirus monoclonal antibody and application

The invention relates to an arenavirus monoclonal antibody and application thereof. Disclosed herein are compositions comprising arenavirus monoclonal antibodies, as well as therapeutic, diagnostic and prophylactic methods using the novel antibodies. The prophylaxis methods include the preparation of vaccines, and factors (e.g., small molecules, peptides) that inhibit the infection of old world arenavirus, including LASV and LCMV. In some embodiments, the antibodies provide pan arenavirus protection against a number of arenavirus types and strains. Also disclosed are diagnostic and therapeutic antibodies including neutralizing antibodies for the prevention and treatment of LASV and other arenavirus infections, as well as novel tools and methods for designing, producing, and using arenavirus monoclonal antibodies, including expression in engineered bacterial-based and mammalian-based systems.
Owner:THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND +3

Gene recombinant attenuated live herpes simplex virus type 2 vaccine

The virus of the present disclosure is a multiple mutant virus in which two or more genes of herpes simplex virus type 2 (HSV-2) are altered and the alteration of the genes is impaired or reduced in gene function.
Owner:THE UNIV OF TOKYO +1

An information processing method, device and equipment for respiratory syncytial virus typing

The present invention discloses an information processing method, device and equipment for respiratory syncytial virus typing, which relates to the technical field of virus classification. The present invention innovatively proposes an information processing method for respiratory syncytial virus typing. On the basis of the original one-hot encoding and zero-padding strategies, a hierarchical one-hot encoding strategy is innovatively proposed, which reduces the interference of the traditional zero-padding method on one-hot encoding and enhances the robustness to insertion mutations. Based on the hierarchical one-hot encoding strategy and neural network image classification technology, it can help doctors and scientific researchers make accurate diagnoses and treatment guidance, improve work efficiency, and help improve the efficiency and diagnosis and treatment quality of the medical and public safety industries.
Owner:四川脉得影深信息技术有限公司

TaqMan fluorescent quantitative PCR primer set for monkey varicella virus and its application

The present invention provides a monkey varicella virus TaqMan fluorescent quantitative PCR primer set and application, and relates to the technical field of molecular biology. The present invention uses the conserved region of the monkey varicella virus type 9 genome as the target gene, designs two specific primers and one probe according to the basic principle of TaqMan real-time fluorescent PCR, and establishes a simple, efficient and practical detection method. The monkey varicella virus detection method of the present invention is effective in 10 1 ‑10 11 The sensitivity of the template was 1×10 1 The invention uses TaqMan fluorescent quantitative PCR to accurately quantify monkey varicella virus in real time, which can meet the urgent need of early and accurate clinical diagnosis of monkey varicella virus infection and provide a basis for epidemiological investigation and targeted treatment of monkey varicella virus infection.
Owner:INST OF MEDICAL BIOLOGY CHINESE ACAD OF MEDICAL SCI

Application of EPZ004777 in preparation of product for treating porcine circovirus type 2 infection

According to the application of EPZ004777 in preparation of products for treating porcine circovirus type 2 infection, it is found for the first time that 50 [mu] g / mL of EPZ004777 has a remarkable inhibiting effect on porcine circovirus type 2 in the replication stage, and the EPZ004777 can be applied to preparation of drugs and / or feed additives for treating porcine intestinal coronavirus infection.
Owner:YANGZHOU UNIV

Process for targeted therapy of various preparations for controlling epidemic outbreak by using non-enveloped virus nucleic acid

The invention relates to multiple preparation processes for targeted treatment of a class of non-enveloped virus nucleic acid or early-stage difficult-to-diagnose epidemic situation control. The key point is that different epidemic situations caused by enveloped or non-enveloped viruses are summarized and recognized from thousands of viruses and epidemic situations which are erupted all the time; the light is adopted to activate the methylene blue riboflavin, so that a plurality of enveloped viruses and a plurality of non-enveloped viruses can be respectively inactivated; the light-activated methylene blue riboflavin can be embedded into a virus nucleic acid chain to prevent replication so as to achieve targeted therapy, and the light-activated methylene blue riboflavin compound preparation is firstly used for treatment when virus types are difficult to diagnose in the early stage of an epidemic situation. In order to control epidemic situation propagation as soon as possible, after it is confirmed that enveloped virus infection or non-enveloped virus infection exists, light-activated methylene blue and a light-activated riboflavin preparation are adopted for targeted therapy. The light-activated methylene blue is adopted for treating three or five positive cases of hepatitis B once every two days by 120 milligrams every time, and all the cases are effectively turned to negative. The preparation process comprises the step of preparing the photoactivated methylene blue riboflavin and the capsule of the photoactivated methylene blue riboflavin.
Owner:TUXING (XIAN) PREPARATION EQUIPMENT MANUFACTURING CO LTD

Primer probe group for detecting herpes virus type 1-8 and lyophilized agent and application thereof

The invention relates to the technical field of pathogen detection, in particular to a primer probe group for detecting herpes virus type 1-8 as well as a freeze-drying agent and application of the primer probe group. The primer probe group provided by the invention can be used for performing multiplex PCR detection on the herpes virus type 1-8, has good reagent specificity, has no nonspecific cross reaction with pathogens except the herpes virus type 1-8, has high sensitivity, has the lowest detection limit of 200 copies / mL, and provides a timely, effective, simple and convenient auxiliary detection tool for clinical detection. Furthermore, a freeze-drying agent containing the primer probe group provided by the technical scheme is good in stability, can be stored at normal temperature (1 year) and transported, has intra-group and inter-group variation coefficients of less than 3% when being used for simultaneously detecting the herpes virus type 1-8, is good in repeatability, is a stable, efficient and simple herpes virus type 1-8 detection reagent, and has wide application prospects. The clinical application is convenient.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Yellow dwarf disease resistance related gene MS1 and application thereof

The invention discloses a yellow dwarf disease resistance related gene MS1 and application thereof, and belongs to the technical field of biology. The invention discloses for the first time that the MS gene is a core positive regulation factor of plant broad-spectrum antiviral property through systematic research. Experiments prove that replication and diffusion of various pathogens such as BYDV, BSMV, TRV, PVX and BSCTV can be remarkably inhibited by up-regulating MS expression of plants such as wheat, barley and tobacco, and resistance does not depend on virus types. Mechanism research shows that MS silencing is achieved by enhancing PTGS-mediated RNA silencing and other basic resistance. The discovery breaks through the traditional mindset of'enhancing resistance genes', and a brand new strategy of'removing resistance inhibition factors' is created. The invention proves that MS inhibition can realize multiple virus resistance and does not damage growth and development.
Owner:HENAN AGRICULTURAL UNIVERSITY

Treatment of HSV-2 using megasnuclease

Described herein are compositions and methods for reducing or eliminating latent herpes simplex virus type 2 (HSV-2) in HSV-2 infected cells, or for reducing or eliminating latent HSV-2 reactivation in HSV-2 infected cells, thereby providing viable therapeutic methods for latent HSV-2 infection. The compositions comprise a plurality of viral vectors, where the viral vectors comprise a sequence encoding a HSV-2 specific megasuclease. The method comprises delivering a plurality of one or more viral vectors to the HSV-2 infected cell, where each of the one or more viral vectors comprises a sequence encoding an HSV-2 specific megasuclease.
Owner:FRED HUTCHINSON CANCER RESEARCH CENTER

Selective detection of different dengue virus RNA serotypes using tandem toehold-mediated displacement reactions

Described herein are systems and methods that may be used to differentially detect viral serotype specific nucleic acid. For example, these systems may comprise multiple DNA-nanostructures, capture oligonucleotides and protector oligonucleotides, wherein each DNA-nanostructure and its associated capture oligonucleotide and protector oligonucleotide are specific for a unique viral type or serotype.
Owner:EMORY UNIVERSITY +1

A fusion protein, rabbit hemorrhagic disease virus type 2 self-assembled nanoparticle vaccine and application

The application provides a fusion protein, a rabbit hemorrhagic disease virus type 2 self-assembled nanoparticle vaccine and application, and belongs to the technical field of biological medicine. The application provides a fusion protein, which comprises a first polypeptide, a hinge region of a rabbit hemorrhagic disease virus type 2 capsid protein, a P region of a rabbit hemorrhagic disease virus capsid protein and a second polypeptide connected in sequence; the first polypeptide and the second polypeptide are polypeptides containing four cysteines respectively. The fusion protein RGD4C-HP-RGD4C of the application can self-assemble to form nanoparticles, and the particle size is 40-50 nm. The fusion protein of the application can induce domestic rabbits to produce specific antibodies against RHDV2, produce a strong humoral immune response, and provide complete protection for the domestic rabbits.
Owner:JIANGSU ACAD OF AGRI SCI

Treatment of HSV-2 using a meganuclease

Described herein are compositions and methods for reducing or eliminating latent herpes simplex virus type 2 (HSV-2) from an HSV-2-infected cell, or for reducing or eliminating latent HSV-2 reactivation in an HSV-2-infected cell, leading to a viable curative approach for latent HSV-2 infection. The composition comprises a plurality of viral vectors, wherein the viral vectors comprise a sequence encoding an HSV-2-specific meganuclease. The method comprises delivering to an HSV-2-infected cell a plurality of one or more viral vectors, wherein each of the one or more viral vectors includes a sequence encoding an HSV-2-specific meganuclease.
Owner:FRED HUTCHINSON CANCER CENT

Kit for detecting berberine-resistant virus and application thereof

The invention discloses a kit for detecting berberine-resistant viruses and application of the kit. The kit provided by the invention comprises an antibody or an antigen binding fragment thereof, a buffer agent and a signal generation system, the antibody or the antigen binding fragment thereof comprises a heavy chain complementarity determining region HCDR1-3 and a light chain complementarity determining region LCDR1-3, the sequences of the heavy chain complementarity determining region HCDR1-3 are respectively as shown in SEQ ID NO.5-7, the sequences of the light chain complementarity determining region LCDR1-3 are respectively as shown in SEQ ID NO.8-10, and the signal generation system comprises a buffer agent and a signal generation system. Or the sequences of the heavy chain complementarity determining region HCDR1-3 are respectively shown as SEQ ID NO.15-17, and the sequences of the light chain complementarity determining region LCDR1-3 are respectively shown as SEQ ID NO.18-20. The kit can be used for detecting the berberine-resistant herpes simplex virus type 1, so that the treatment effect can be evaluated in advance before berberine is applied for treatment.
Owner:BEIJING YANQING DISTRICT MARKET SUPERVISION INSPECTION & MONITORING CENTER +1